AbbVie Must Be Sent Message, Jury Told In AndroGel Trial
Attorneys for a man who suffered a heart attack while on AbbVie's AndroGel wrapped up their case Thursday, telling an Illinois federal jury that the pharmaceutical company won't change the way...To view the full article, register now.
Already a subscriber? Click here to view full article